Use of Vitamin K2 (Menatetrenone) and 1,25-dihydroxyvitamin D3 in the Prevention of Bone Loss Induced by Leuprolide
- 1 August 1999
- journal article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 84 (8) , 2700-2704
- https://doi.org/10.1210/jc.84.8.2700
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: